Albany, NY -- (SBWire) -- 05/25/2018 --Global Single-use Bioprocessing Systems Market: Analyst's Estimations

The healthcare industry, as a whole, has always been on an upward curve, because wellness is paramount for humanity. The prosperity of the healthcare industry can also be credited to its pursuit of excellence, evolving continuously and adopting the next technology that can yield better medical results. In the past decade, single-use bioprocessing systems have emerged as a viable alternative to reusable bioprocessing systems when it comes to media preparation and storage, cell harvesting fermentation, buffer preparation, and purification. On the back of increased investment on clinical research by various private and public bodies, the market for single-use bioprocessing systems is flourishing.

According to this business intelligence report, the demand in the global single-use bioprocessing systems market will expand at an impressive CAGR of 11.3% during the forecast period of 2017 to 2024. Revenue-wise, total opportunities in this market are estimated to attain a valuation of US$5,914.6 million by the end of 2024, mounting-up from its evaluated worth of US$2,791.4 million as of 2017. The report has also emphasized on examining the lucrativeness of the North America single-use bioprocessing systems market, which is estimated to be worth US$1,596.4 million by 2024, with the regional demand multiplying at a CAGR of 11.3% during 2017 to 2024.

Some of the key factors primed to drive the single-use bioprocessing systems market are: customization of products as per the need of consumers, benefits of overall reduction in costs and processing time, growth in the production of monoclonal antibodies, and rise in contract manufacturing and outsourcing activities in the biopharmaceutical industry. On the other hand, technical difficulties pertaining to large-scale bio-production and disposal are a few restraints curtailing the progress of this market. The trend of R&D outsourcing is expected to open new opportunities in this market.

Bags, Bioreactors, and Fermenters Leading Product Segments

Product-wise, this report segments the single-use bioprocessing systems market into bioreactors and fermenters, bags, bioprocess containers, mixers, filtration devices, tubing, connectors and clamps, sampling systems, and probes and sensors. Among these, bags and bioreactors and fermenters have been identified as the two product segments with maximum demand. While the single-use processing bags segment is estimated to generate a revenue of 1,595.2 million by the end of 2024, the opportunities in the single-use bioreactors and fermenters market is projected to attain a valuation of US$1,237.7 million by 2024.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3753

Robust growth of bioprocessing bags is due to repeat purchases for several upstream and downstream functions such as mixing, filtration, storage, transport, and media preparation and fermentation. Acceptability in wide applications and ability to be customized according to user requirements is likely to augment the segment during the forecast period. On the other hand, strong growth of the bioreactors and fermenters segment can be attributed to several factors such as the expansion of R&D facilities of major pharmaceutical organizations, higher adoption of single-use technologies by CMOs and CROs producing biologics, and rise in consumer awareness about the benefits of single-use bioreactors.

Monoclonal Antibody Production Key Application Segment

Application-wise, the single-use bioprocessing products market has been classified into monoclonal antibody production, vaccine production, patient specific cell therapies, plant cell cultivation, and others. Monoclonal antibody production has been detected as the key application segment of the market, promising to provide for a demand worth of US$3,904.8 mn by the end of 2024, which will be nearly two-third of the overall demand.

Based on end-users, the market for single-use bioprocessing systems has been bifurcated into pharmaceutical, contract research and contract manufacturing organizations (CROs and CMOs), biotechnology, and academic and research institutes. The first three end-users have been identified as the most profitable ones, and in that order.

Europe Most Profitable Region by a Slender Marginal

Out of the five regions evaluated for their potential of demand for single-use bioprocessing systems, viz. Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America, the first three have been highlighted as the key regions. Driven by a larger consumer base that is making the transition from stainless steel to single-use set-ups in their manufacturing facilities, the Europe single-use bioprocessing systems market is estimated to be worth US$1,680.0 million by the end of 2024. On the other hand, the demand from the region of Asia Pacific is primed to expand at the strongest CAGR of 12.6% during the period of 2017 to 2024. Mushrooming of biotech start-ups and greater influx of contract manufacturers in the emerging economies of India and China is driving the APAC single-use bioprocessing systems market.

Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3753

The report identifies Sartorius AG, Pall Corporation, Thermo Fisher Scientific, GE Healthcare, and Merck KGaA as the leading companies in a highly consolidated vendor landscape of the global single-use bioprocessing systems market.